Nicole E Chambers, Ph.D.
Postdoctoral Associate
Department:
MD-PHARMACOLOGY / THERAPEUTICS
Business Email:
nicole.chambers@ufl.edu
Research Profile
Mentor: Mark Moehle, PhD
Areas of Interest
- Movement Disorders
Publications
Academic Articles
2024
Conditional Knockout of Striatal Gnal Produces Dystonia-like Motor Phenotypes.
bioRxiv : the preprint server for biology.
[DOI] 10.1101/2024.08.26.609754.
[PMID] 39253490.
2024
G α olf Regulates Biochemical Signaling in Neurons Associated with Movement Control and Initiation.
bioRxiv : the preprint server for biology.
[DOI] 10.1101/2024.04.03.587766.
[PMID] 38617339.
2024
Neuron specific quantitation of Gαolf expression and signaling in murine brain tissue.
Brain research.
1842
[DOI] 10.1016/j.brainres.2024.149105.
[PMID] 38960060.
2023
The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders.
Biochemical Society transactions.
51(2):691-702
[DOI] 10.1042/BST20220525.
[PMID] 37013974.
2021
Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
The European journal of neuroscience.
53(8):2835-2847
[DOI] 10.1111/ejn.15106.
[PMID] 33426708.
2020
Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
Psychopharmacology.
237(1):155-165
[DOI] 10.1007/s00213-019-05353-6.
[PMID] 31435690.
2019
Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat.
Neuroscience.
409:180-194
[DOI] 10.1016/j.neuroscience.2019.04.008.
[PMID] 31029732.
2019
Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease.
Frontiers in pharmacology.
10
[DOI] 10.3389/fphar.2019.01494.
[PMID] 32009944.
2019
Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia.
Acta neuropathologica communications.
7(1)
[DOI] 10.1186/s40478-018-0653-7.
[PMID] 30646956.
2018
A new outlook on cholinergic interneurons in Parkinson’s disease and L-DOPA-induced dyskinesia.
Neuroscience and biobehavioral reviews.
92:67-82
[DOI] 10.1016/j.neubiorev.2018.05.021.
[PMID] 29782883.
2018
Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia.
Neuropharmacology.
138:304-314
[DOI] 10.1016/j.neuropharm.2018.06.024.
[PMID] 29936243.
2018
Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats.
Movement disorders : official journal of the Movement Disorder Society.
33(11):1740-1749
[DOI] 10.1002/mds.100.
[PMID] 30485908.
2017
Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia.
Experimental neurology.
292:168-178
[DOI] 10.1016/j.expneurol.2017.03.013.
[PMID] 28342749.
2015
Relative reward effects on operant behavior: Incentive contrast, induction and variety effects.
Behavioural processes.
116:87-99
[DOI] 10.1016/j.beproc.2015.05.003.
[PMID] 25979604.
Education
Ph.D. Behavioral Neuroscience
2014-2020
·
Binghamton University
M.S. Psychological Science
2012-2015
·
Western Kentucky University
B.A. Music, French, and Psychology (Triple Major)
2007-2012
·
Bowling Green State University
Contact Details
Emails:
- Business:
- nicole.chambers@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100267
GAINESVILLE FL 32610